No abstract

AF is very frequent in patients with multiple myeloma when they receive ASCT. The presence of abnormal renal function, left ventricular systolic dysfunction, dilated left atrium, or hypertension at baseline identifies patients at high risk of developing AF following ASCT.

MDCT can be a useful tool to measure LVEF while patients are undergoing CT coronary angiography.

No abstract

No abstract

No abstract

Cardiovascular diseases, especially myocardial ischemia, have been a leading cause of death worldwide for several decades. Despite major advances in the diagnostic and therapeutic modalities available for the clinical management of patients with cardiovascular disease, significant limitations remain. The use of very small molecular particles has recently emerged as a novel technique for diagnostic imaging and treatment of a variety of disease processes and can be broadly classified under the category Nanomedicine. Many diagnostic and therapeutic modalities based on these small molecular particles have become part of routine clinical practice, such as liposomal amphotericin B for the treatment of fungal infections and iron nanoparticles for imaging liver tumors. In this review, we discuss the potential applications of nanomedicine in the management of cardiovascular diseases.

Mexiletine is a commonly used Class IB (Vaughan William classification) antiarrhythmic drug. We report a case of mexiletine-induced psychosis that was successfully managed by decreasing the dose and using alternative medications for management of ventricular tachycardia.